{
  "id": "64136664201352f04a00003b",
  "type": "list",
  "question": "What are the main clinical features of small-fiber neuropathy (SFN)?",
  "ideal_answer": "The main clinical features of small-fiber neuropathy (SFN) include pain, sensory disturbances, and autonomic dysfunction.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32654574",
    "http://www.ncbi.nlm.nih.gov/pubmed/36430572",
    "http://www.ncbi.nlm.nih.gov/pubmed/30247738",
    "http://www.ncbi.nlm.nih.gov/pubmed/23982054",
    "http://www.ncbi.nlm.nih.gov/pubmed/34698404",
    "http://www.ncbi.nlm.nih.gov/pubmed/29029847",
    "http://www.ncbi.nlm.nih.gov/pubmed/18524793",
    "http://www.ncbi.nlm.nih.gov/pubmed/17948213",
    "http://www.ncbi.nlm.nih.gov/pubmed/30125923",
    "http://www.ncbi.nlm.nih.gov/pubmed/35130356",
    "http://www.ncbi.nlm.nih.gov/pubmed/30569495",
    "http://www.ncbi.nlm.nih.gov/pubmed/36005471"
  ],
  "snippets": [
    {
      "text": " Selective SFN (without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction. T",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35130356",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neuropathic pain (NP) is a main feature of Fabry disease (FD) as consequence of small fiber neuropathy. Restless legs syndrome (RLS) in FD was not described, but it is an important feature in other small fiber neuropathies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17948213",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "mall fiber neuropathy (SFN) can be associated with autoantibodies, including those of IgM class with specificity for the trisulfated heparan disaccharide (TS-HDS) antigen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34698404",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Up to 50% of small fiber neuropathy (SFN) cases are idiopathic, but novel antibodies to Trisulfated Heparin Disaccharide (TS-HDS) and fibroblast growth factor receptor 3 (FGFR-3) have been implicated in half of these cases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36005471",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "an the patients without SFN. Restless leg syndrome was also more frequently observed in patients with SFN, who had pain aggravated at rest that improved by moving.CONCLUSIONS: These findings are in favor of the sensitization of relatively spared large A\u03b2-fibers and second-order",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30247738",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Small fiber neuropathies (SFN) comprise a clinical syndrome typically associated with acral burning pain, where the pathophysiological processes affect the thinly myelinated A-delta and the unmyelinated C nerve fibers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30125923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Small fibre neuropathy (SFN), a condition dominated by neuropathic pain, is frequently encountered in clinical practise either as prevalent manifestation of more diffuse neuropathy or distinct nosologic entity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18524793",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neuropathic pain is a characteristic feature of small fiber neuropathy (SFN), which in 18% of the cases is caused by genetic variants in voltage-gated sodium ion channels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36430572",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SFN was defined by the presence of suggestive sensory painful symptoms with normal nerve conduction studies and abnormal neurophysiologic tests for small nerve fibers or a low intraepidermal nerve fiber density at skin biopsy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982054",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SFN is clinically dominated by neuropathic pain and autonomic complaints, leading to a significant reduction in quality of life.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30569495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Small-fiber neuropathy (SFN) is a disorder of thinly myelinated A\u03b4 and unmyelinated C fibers. SFN is clinically dominated by neuropathic pain and autonomic complaints, leading to a significant reduction in quality of life.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30569495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Small fiber neuropathy (SFN) is a heterogeneous group of disorders affecting thin myelinated A\u03b4 and unmyelinated C fibers. Common symptoms include neuropathic pain and autonomic disturbances, and the typical clinical presentation is that of a length-dependent polyneuropathy, although other distributions could be present.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32654574",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Small fiber neuropathy (SFN) is a peripheral nervous system disease due to affection of A-delta or C-fibers in a proximal, distal, or diffuse distribution. Selective SFN (without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction. Though uniform diagnostic criteria are unavailable, most of them request typical clinical features and reduced intra-epidermal nerve fiber density on proximal or distal skin biopsy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35130356",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Small fibre neuropathies are a heterogeneous group of disorders affecting thinly myelinated A\u03b4-fibres and unmyelinated C-fibres. Although multiple causes of small nerve fibre degeneration have been reported, including via genetic mutations, the cause of small fibre neuropathy remains unknown in up to 50% of cases. The typical clinical presentation of small fibre neuropathy is that of a symmetrical, length-dependent polyneuropathy associated with sensory or autonomic symptoms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29029847",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "pain, sensory disturbance, autonomic dysfunction, restless leg syndrome, autoantibodies"
}